{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:16:38Z","timestamp":1793657798261,"version":"4.5.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T00:00:00Z","timestamp":1728518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T00:00:00Z","timestamp":1728518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82273691"],"award-info":[{"award-number":["82273691"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"crossref","award":["BK20190106"],"award-info":[{"award-number":["BK20190106"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Nanjing Important Science & Technology Specific Projects","award":["2021-11005"],"award-info":[{"award-number":["2021-11005"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Youth Science Foundation of China","doi-asserted-by":"crossref","award":["81703273"],"award-info":[{"award-number":["81703273"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Priority Academic Program Development of Jiangsu Higher Education Institutions","award":["PAPD"],"award-info":[{"award-number":["PAPD"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-75280-w","type":"journal-article","created":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T12:03:01Z","timestamp":1728561781000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["DAA treatment for HCV reduce risk of hepatocellular carcinoma: a 10-years follow-up study based on Chinese patients with hepatitis C"],"prefix":"10.1038","volume":"14","author":[{"given":"Xiaobo","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linna","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueshan","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongbin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,10]]},"reference":[{"issue":"6","key":"75280_CR1","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1002\/hep.21176","volume":"43","author":"A Sangiovanni","year":"2006","unstructured":"Sangiovanni, A. et al. The natural history of compensated cirrhosis due to hepatitis C virus: A 17-year cohort study of 214 patients. Hepatology 43(6), 1303\u20131310 (2006).","journal-title":"Hepatology"},{"issue":"3","key":"75280_CR2","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.cgh.2009.11.018","volume":"8","author":"AG Singal","year":"2010","unstructured":"Singal, A. G., Volk, M. L., Jensen, D., Di Bisceglie, A. M. & Schoenfeld, P. S. A sustained viral response is associated with reduced liver-related morbidity and mortality in patients with hepatitis C virus. Clin. Gastroenterol. Hepatol. 8(3), 280\u2013288 (2010).","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"1 Suppl","key":"75280_CR3","doi-asserted-by":"publisher","first-page":"S95","DOI":"10.1016\/j.jhep.2016.07.039","volume":"65","author":"AJ van der Meer","year":"2016","unstructured":"van der Meer, A. J. & Berenguer, M. Reversion of disease manifestations after HCV eradication. J. Hepatol. 65(1 Suppl), S95\u2013S108 (2016).","journal-title":"J. Hepatol."},{"issue":"4","key":"75280_CR4","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1093\/infdis\/jis385","volume":"206","author":"MH Lee","year":"2012","unstructured":"Lee, M. H. et al. Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: A community-based long-term prospective study. J. Infect. Dis. 206(4), 469\u2013477 (2012).","journal-title":"J. Infect. Dis."},{"issue":"1","key":"75280_CR5","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1053\/j.gastro.2016.03.036","volume":"151","author":"V Di Marco","year":"2016","unstructured":"Di Marco, V. et al. Effects of eradicating hepatitis C virus infection in patients with cirrhosis differ with stage of portal hypertension. Gastroenterology 151(1), 130-139.e2 (2016).","journal-title":"Gastroenterology"},{"issue":"24","key":"75280_CR6","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1001\/jama.2012.144878","volume":"308","author":"AJ van der Meer","year":"2012","unstructured":"van der Meer, A. J. et al. Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis. JAMA 308(24), 2584\u20132593 (2012).","journal-title":"JAMA"},{"issue":"8","key":"75280_CR7","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1111\/liv.13707","volume":"38","author":"R D\u2019Ambrosio","year":"2018","unstructured":"D\u2019Ambrosio, R. et al. Persistence of hepatocellular carcinoma risk in hepatitis C patients with a response to IFN and cirrhosis regression. Liver Int. 38(8), 1459\u20131467 (2018).","journal-title":"Liver Int."},{"key":"75280_CR8","unstructured":"European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; Clinical Practice Guidelines Panel: Chair:; EASL Governing Board representative:; Panel members:. EASL recommendations on treatment of hepatitis C: Final update of the series\u2606. J. Hepatol. 73(5), 1170\u20131218 (2020)."},{"issue":"10179","key":"75280_CR9","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(18)32111-1","volume":"393","author":"F Carrat","year":"2019","unstructured":"Carrat, F. et al. Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: A prospective cohort study. Lancet 393(10179), 1453\u20131464 (2019).","journal-title":"Lancet"},{"issue":"6","key":"75280_CR10","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1002\/hep.29097","volume":"65","author":"C Fern\u00e1ndez Carrillo","year":"2017","unstructured":"Fern\u00e1ndez Carrillo, C. et al. Treatment of hepatitis C virus infection in patients with cirrhosis and predictive value of model for end-stage liver disease: Analysis of data from the Hepa-C registry. Hepatology 65(6), 1810\u20131822 (2017).","journal-title":"Hepatology"},{"key":"75280_CR11","unstructured":"Ioannou, G. N., Green, P. K. & Berry, K. HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma [published online ahead of print, 2017 Sep 5]. J. Hepatol. S0168\u20138278(17), 32273-0 (2017)."},{"issue":"8","key":"75280_CR12","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1111\/jvh.13295","volume":"27","author":"NZ Janjua","year":"2020","unstructured":"Janjua, N. Z. et al. The impact of SVR from direct-acting antiviral-and interferon-based treatments for HCV on hepatocellular carcinoma risk. J. Viral Hepat. 27(8), 781\u2013793 (2020).","journal-title":"J. Viral Hepat."},{"issue":"2","key":"75280_CR13","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/hep.29408","volume":"69","author":"LI Backus","year":"2019","unstructured":"Backus, L. I., Belperio, P. S., Shahoumian, T. A. & Mole, L. A. Impact of sustained virologic response with direct-acting antiviral treatment on mortality in patients with advanced liver disease. Hepatology 69(2), 487\u2013497 (2019).","journal-title":"Hepatology"},{"issue":"4","key":"75280_CR14","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1053\/j.gastro.2017.06.012","volume":"153","author":"F Kanwal","year":"2017","unstructured":"Kanwal, F. et al. Risk of hepatocellular cancer in HCV patients treated with direct-acting antiviral agents. Gastroenterology 153(4), 996-1005.e1 (2017).","journal-title":"Gastroenterology"},{"issue":"4","key":"75280_CR15","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.jhep.2016.06.015","volume":"65","author":"F Conti","year":"2016","unstructured":"Conti, F. et al. Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals. J. Hepatol. 65(4), 727\u2013733 (2016).","journal-title":"J. Hepatol."},{"key":"75280_CR16","doi-asserted-by":"crossref","unstructured":"Li, D. K., Ren, Y., Fierer, D. S., Rutledge, S., Shaikh, O. S. & Lo Re, V. 3rd. et al. The short-term incidence of hepatocellular carcinoma is not increased after hepatitis C treatment with direct-acting antivirals: An ERCHIVES study. Hepatology 67(6), 2244\u20132253 (2018).","DOI":"10.1002\/hep.29707"},{"key":"75280_CR17","doi-asserted-by":"crossref","unstructured":"Myers, R. P., Shah, H., Burak, K. W., Cooper, C. & Feld, J. J. An update on the management of chronic hepatitis C: 2015 Consensus guidelines from the Canadian Association for the Study of the Liver [published correction appears in Can. J. Gastroenterol. Hepatol. 29(2), 68 (2015)]. Can. J. Gastroenterol. Hepatol 29(1), 19\u201334 (2015).","DOI":"10.1155\/2015\/692408"},{"issue":"3","key":"75280_CR18","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.jhep.2016.10.028","volume":"66","author":"NZ Janjua","year":"2017","unstructured":"Janjua, N. Z. et al. Long-term effect of sustained virological response on hepatocellular carcinoma in patients with hepatitis C in Canada. J. Hepatol. 66(3), 504\u2013513 (2017).","journal-title":"J. Hepatol."},{"issue":"5","key":"75280_CR19","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.jhep.2020.11.021","volume":"74","author":"LAP Krassenburg","year":"2021","unstructured":"Krassenburg, L. A. P. et al. Clinical outcomes following DAA therapy in patients with HCV-related cirrhosis depend on disease severity. J. Hepatol. 74(5), 1053\u20131063 (2021).","journal-title":"J. Hepatol."},{"issue":"5","key":"75280_CR20","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.jhep.2021.05.028","volume":"75","author":"NZ Janjua","year":"2021","unstructured":"Janjua, N. Z. et al. Impact of direct-acting antivirals for HCV on mortality in a large population-based cohort study. J. Hepatol. 75(5), 1049\u20131057 (2021).","journal-title":"J. Hepatol."},{"issue":"5","key":"75280_CR21","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1053\/j.gastro.2018.07.015","volume":"155","author":"P Nahon","year":"2018","unstructured":"Nahon, P. et al. Incidence of hepatocellular carcinoma after direct antiviral therapy for HCV in patients with cirrhosis included in surveillance programs. Gastroenterology. 155(5), 1436\u20131450 (2018).","journal-title":"Gastroenterology."},{"key":"75280_CR22","doi-asserted-by":"crossref","unstructured":"Butt, A. A, Yan, P., Shaikh, O. S., Lo Re, V 3rd., Abou-Samra, A. B. & Sherman, K. E. Treatment of HCV reduces viral hepatitis-associated liver-related mortality in patients: An ERCHIVES study. J. Hepatol 73(2), 277\u2013284 (2020).","DOI":"10.1016\/j.jhep.2020.02.022"},{"issue":"3","key":"75280_CR23","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1002\/hep.29811","volume":"68","author":"LI Backus","year":"2018","unstructured":"Backus, L. I., Belperio, P. S., Shahoumian, T. A. & Mole, L. A. Direct-acting antiviral sustained virologic response: Impact on mortality in patients without advanced liver disease. Hepatology 68(3), 827\u2013838 (2018).","journal-title":"Hepatology"},{"issue":"7","key":"75280_CR24","doi-asserted-by":"publisher","first-page":"e2011055","DOI":"10.1001\/jamanetworkopen.2020.11055","volume":"3","author":"Y Kalidindi","year":"2020","unstructured":"Kalidindi, Y., Jung, J., Feldman, R. & Riley, T. 3rd. Association of direct-acting antiviral treatment with mortality among medicare beneficiaries with hepatitis C. JAMA Netw. Open 3(7), e2011055 (2020).","journal-title":"JAMA Netw. Open"},{"key":"75280_CR25","unstructured":"Nahon, P., Bourcier, V., Layese, R., Audureau, E., Cagnot, C. & Marcellin, P. et al. Eradication of hepatitis C virus infection in patients with cirrhosis reduces risk of liver and non-liver complications [published correction appears in Gastroenterology. 161(1), 377 (2021)]. Gastroenterology 152(1), 142\u2013156 (2017)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75280-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75280-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75280-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T12:04:36Z","timestamp":1728561876000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75280-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,10]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["75280"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-75280-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,10]]},"assertion":[{"value":"17 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23760"}}